Cabaletta Bio, Inc.
CABA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001759138
No open-market purchases or sales by Cabaletta Bio, Inc. insiders were filed in the last 90 days; 139 institutions reported holding it in 13F filings for Q2 2026, worth $490.4M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Cabaletta Bio, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 86
- −7 vs. Q1 2025
- Shares held
- 72.8M
- +36.5M (+100.4%) vs. Q1 2025
- Total value
- $110.7M
- +$60.3M (+119.9%) vs. Q1 2025
- New holders
- 26
- 23 more added
- Sold out
- 33
- 28 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CABA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 139 | $490.4M |
| Q1 2026 | 108 | $227.5M |
| Q4 2025 | 95 | $166.9M |
| Q3 2025 | 75 | $162.0M |
| Q2 2025 | 86 | $110.7M |
| Q1 2025 | 93 | $50.3M |
| Q4 2024 | 109 | $87.2M |
| Q3 2024 | 120 | $226.7M |
| Q2 2024 | 142 | $380.0M |
| Q1 2024 | 159 | $870.9M |
| Q4 2023 | 128 | $1.10B |
| Q3 2023 | 97 | $622.6M |
| Q2 2023 | 84 | $470.5M |
| Q1 2023 | 72 | $203.9M |
| Q4 2022 | 61 | $183.9M |
| Q3 2022 | 54 | $7.76M |
| Q2 2022 | 55 | $17.8M |
| Q1 2022 | 62 | $36.9M |
| Q4 2021 | 66 | $68.9M |
| Q3 2021 | 61 | $211.3M |
| Q2 2021 | 63 | $135.5M |
| Q1 2021 | 68 | $180.1M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Cabaletta Bio, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Avanza Fonder AB | 0 | $0 | 0.00% | −17,605−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −15,405−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −12,981−100.0% | Sold out |
| Police & Firemen's Retirement System of New Jersey | 0 | $0 | 0.00% | −12,628−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −12,181−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −10,565−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −10,412−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −3,961−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −3,452−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −3,338−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,175−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −1,409−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −990−100.0% | Sold out |
| Sterling Capital Management LLC | 0 | $0 | 0.00% | −636−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −280−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −231−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −151−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | 0 | Sold out |